Calidi Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.07

-0.06 (-5.31%)

As of Sep 28, 10:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,417.8% upside

Low Target $29.39

Average Target $48.34

High Target $58.89

Current Price $1.07

Current
$1.07

Target
$48.34

$29.39 $48.34 avg $58.89

Scenario Analysis

Bear Case

$29.39

2,646.7%

Low target

Base Case

$48.34

+4,417.8%

Avg target

Bull Case

$58.89

+5,403.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$27.84

-96.2% from high

52-Week Low

$1.05

+1.9% from low

Target vs 52W High

$48.34

+73.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%